Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

Largest childhood preventative health initiative in nearly 20 yearsBeyfortus rollout to ensure all babies are RSV protected this winterThe largest ...

The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) reported 15 more H5N1 avian flu ...

As healthcare evolves at a remarkable pace, innovation in pharmaceuticals has become more than a matter of science but rather a matter of public impact. Few scientists embody this convergence better ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Learn more about whether Blueprint Medicines Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alkermes plc or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...